Keywords: NICE, UK, Johnson & Johnson, Stelera, Psoriasis

Janssen-Cilag's Stelara backed by UK’s NICE for moderate-to-severe plaque psoriasis

Article | 23 September 2009

Print This

Janssen-Cilag, a Johnson & Johnson company, says that its Stelara (ustekinumab) has today been approved by the UK’s National Institute ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in